Diebold (DBD) Reports In-Line Q4 EPS, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $65.27 -1.82%
Financial Fact:
Net income attributable to Diebold, Incorporated: -0.32
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Net income attributable to Diebold, Incorporated: -0.32
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Diebold (NYSE: DBD) reported Q4 EPS of $0.32, in-line with the analyst estimate of $0.32. Revenue for the quarter came in at $1.25 billion versus the consensus estimate of $1.31 billion.
GUIDANCE:
Diebold sees 2017 EPS of $1.40-$1.70, versus the consensus of $1.62. Diebold sees 2017 revenue of $5-5.1 billion, versus the consensus of $5.09 billion.
For earnings history and earnings-related data on Diebold (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- RH shares jump after second quarter beat
- Frequency Electronics (FEIM) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
